Zyla Life Sciences Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zyla Life Sciences.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Zyla Life Sciences for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | M | 0.00 | 29,000 | 0 | 0 | |
| Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | M | 0.00 | 33,000 | 0 | 0 | |
| Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Payment of Exercise | F | 1.60 | 17,038 | 27,261 | 44,962 | 62 K to 45 K (-27.48 %) |
| Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Buy | M | 1.60 | 29,000 | 46,400 | 62,000 | 33 K to 62 K (+87.88 %) |
| Mar 26 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Buy | M | 1.60 | 33,000 | 52,800 | 33,000 | 0 to 33 K |
| Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | M | 0.00 | 14,334 | 0 | 0 | |
| Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Payment of Exercise | F | 1.60 | 9,435 | 15,096 | 24,899 | 34.3 K to 24.9 K (-27.48 %) |
| Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Buy | M | 1.60 | 14,334 | 22,934 | 34,334 | 20 K to 34.3 K (+71.67 %) |
| Mar 26 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Buy | M | 1.60 | 20,000 | 32,000 | 20,000 | 0 to 20 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | A | 1.50 | 84,700 | 127,050 | 84,700 | |
| Mar 05 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Grant | A | 0.00 | 58,000 | 0 | 58,000 | 0 to 58 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | A | 1.50 | 116,400 | 174,600 | 116,400 | |
| Mar 05 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Grant | A | 0.00 | 79,800 | 0 | 79,800 | 0 to 79.8 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Option Exercise | A | 1.50 | 241,500 | 362,250 | 241,500 | |
| Mar 05 2020 | EGLT | Zyla Life Sciences | SMITH TODD N | President and CEO | Grant | A | 0.00 | 165,500 | 0 | 165,500 | 0 to 165.5 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | Walbert Timothy P | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | Smiley Andrea Heslin | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | Pauls Matthew | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | McInnis Joe | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
| Mar 05 2020 | EGLT | Zyla Life Sciences | Phillips Gary M. | Director | Grant | A | 0.00 | 13,620 | 0 | 13,620 | 0 to 13.6 K |
| Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | M | 0.00 | 18,810 | 0 | 0 | |
| Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Option Exercise | M | 0.00 | 21,285 | 0 | 0 | |
| Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Payment of Exercise | F | 1.50 | 10,805 | 16,208 | 29,290 | 40.1 K to 29.3 K (-26.95 %) |
| Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Buy | M | 1.50 | 18,810 | 28,215 | 40,095 | 21.3 K to 40.1 K (+88.37 %) |
| Mar 02 2020 | EGLT | Zyla Life Sciences | TIMMINS MEGAN C. | General Counsel | Buy | M | 1.50 | 21,285 | 31,928 | 21,285 | 0 to 21.3 K |
| Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | M | 0.00 | 32,670 | 0 | 0 | |
| Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Option Exercise | M | 0.00 | 43,065 | 0 | 0 | |
| Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Payment of Exercise | F | 1.50 | 20,812 | 31,218 | 54,923 | 75.7 K to 54.9 K (-27.48 %) |
| Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Buy | M | 1.50 | 32,670 | 49,005 | 75,735 | 43.1 K to 75.7 K (+75.86 %) |
| Mar 02 2020 | EGLT | Zyla Life Sciences | Strobeck Mark | Chief Operating Off ... | Buy | M | 1.50 | 43,065 | 64,598 | 43,065 | 0 to 43.1 K |